07:00 , Mar 24, 2008 |  BioCentury  |  Finance

Nomura's investments

Nomura's investments Nomura's investments Nomura Phase4 Ventures has invested in at least 25 biotechs since 1999. Usually Nomura's contribution for an initial investment will be some $15-$25 million of the round, although in subsequent rounds...
07:00 , Aug 8, 2005 |  BioCentury  |  Product Development

Corporate Profile

IntegraGen S.A. Evry, France Technology: GenomeHIP (Genome Hybrid Identity Profiling) Disease focus: Endocrine, neurology Clinical status: Market Founded: 2000 by Joerg Hager, Philippe Gesnouin, Peter Brooks, Anne Philippi, Nathalie Vionnet University collaborators: Hopital Hotel-Dieu; Hopital...
03:24 , Feb 23, 2005 |  BC Extra  |  Financial News

Zealand raises EUR 13M

Zealand (Glostrup, Denmark) raised EUR 13 million ($17 million) in a second closing of its series C round, bringing to EUR 26 million ($34 million) the total raised. Investors in the second closing were CDC...